Bioactive Compounds
-
N1856 Hesperitin -
BA2351 TH1338Summary: TH1338, an orally active derivative of camptothecin, is a promising anticancer compound that exhibits excellent tumor cytotoxicity in vitro. - C8383 Sulfo-Cy3-TetrazineSummary: Sulfo-Cy3-Tetraazine is a click chemistry containing a tetrazine moiety.
- BA3076 MIR96-IN-1Summary: MIR96-IN-1 targets the Drosha site in the hairpin precursor structure, inhibits its biogenesis, as well as inhibits downstream targets, and triggers apoptosis in breast cancer cells.
- BA1120 FinafloxacinSummary: Fluoroquinolone anti-microbial agent with optimal efficacy in a slightly acidic environment.
- BA2349 Gly-7-MAD-MDCPTSummary: Gly-7-MAD-MDCPT is an anticancer agent.
- C8382 5-Br-PAPSSummary: 5-Br-PAPS is a Zn metal indicator with high specificity.
- BA3075 CID5721353Summary: CID5721353 is an inhibitor.
-
N1656 Schizandrin BTarget: Nrf2|ROS and Other Gaseous DonorsSummary: inhibits lipid peroxidation -
N1852 Chrysophanol